- Home
- BSRR vs PRLD Comparison
BSRR vs PRLD Comparison
Compare BSRR & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSRR | PRLD |
|---|---|---|
| Founded | 1977 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.7M | 391.1M |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BSRR | PRLD |
|---|---|---|
| Price | $42.91 | $4.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $37.00 | $5.67 |
| AVG Volume (30 Days) | 61.1K | ★ 560.0K |
| Earning Date | 04-27-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | 10.28 | ★ 23.21 |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | $11.74 | $320.10 |
| Revenue Next Year | $3.63 | $100.00 |
| P/E Ratio | $44.77 | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $26.49 | $0.75 |
| 52 Week High | $43.13 | $5.69 |
Technical Indicators
Market Signals| Indicator | BSRR | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 69.78 | 41.03 |
| Support Level | $35.43 | $3.92 |
| Resistance Level | N/A | $4.13 |
| Average True Range (ATR) | 1.09 | 0.45 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 93.39 | 4.49 |
Price Performance
Historical ComparisonAbout BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.